In non-small-cell lung carcinoma (NSCLC), for instance, tumor infiltrating NK cells are associated with a distinct surface receptor profile, characterized by lower expression of NKp30, NKp80, NKG2D, DNAM-1, and CD16 [73]. This evidence concerns the gene CD226 and neoplasm.